Literature DB >> 20627882

Role of fibrinogen in trauma-induced coagulopathy.

D Fries1, W Z Martini.   

Abstract

Coagulation defects related to severe trauma, trauma-induced coagulopathy (TIC), have a number of causal factors including: major blood loss with consumption of clotting factors and platelets, and dilutional coagulopathy after administration of crystalloids and colloids to maintain blood pressure. In addition, activation of the fibrinolytic system or hyperfibrinolysis, hypothermia, acidosis, and metabolic changes can also affect the coagulation system. All of these directly affect fibrinogen polymerization and metabolism. Other bleeding-related deficiencies usually develop later in massive bleeding related to severe multiple trauma. In major blood loss, fibrinogen reaches a critical value earlier than other procoagulatory factors, or platelets. The question of the critical threshold value is presently the subject of heated debate. A threshold of 100 mg dl(-1) has been recommended, but recent clinical data have shown that at a fibrinogen level of <150-200 mg dl(-1), there is already an increased tendency to peri- and postoperative bleeding. A high fibrinogen count exerts a protective effect with regard to the amount of blood loss. In multiple trauma patients, priority must be given to early and effective correction of impaired fibrin polymerization by administering fibrinogen concentrate.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20627882     DOI: 10.1093/bja/aeq161

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  55 in total

1.  Variability in international normalized ratio and activated partial thromboplastin time after injury are not explained by coagulation factor deficits.

Authors:  Gregory R Stettler; Ernest E Moore; Hunter B Moore; Geoffrey R Nunns; Julia R Coleman; Arthur Colvis; Arsen Ghasabyan; Mitchell J Cohen; Christopher C Silliman; Anirban Banerjee; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2019-09       Impact factor: 3.313

2.  Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document".

Authors:  Santiago R Leal-Noval; Manuel Muñoz; Marisol Asuero; Enric Contreras; José A García-Erce; Juan V Llau; Victoria Moral; José A Páramo; Manuel Quintana
Journal:  Blood Transfus       Date:  2013-06-17       Impact factor: 3.443

3.  Kinetic model facilitates analysis of fibrin generation and its modulation by clotting factors: implications for hemostasis-enhancing therapies.

Authors:  Alexander Y Mitrophanov; Alisa S Wolberg; Jaques Reifman
Journal:  Mol Biosyst       Date:  2014-07-29

4.  Fibrinogen concentrate improves survival during limited resuscitation of uncontrolled hemorrhagic shock in a Swine model.

Authors:  Nathan J White; Xu Wang; Conrad Liles; Susan Stern
Journal:  Shock       Date:  2014-11       Impact factor: 3.454

Review 5.  [The TraumaRegister DGU® dataset, its development over 25 years and advances in the care of severely injured patients].

Authors:  H Trentzsch; M Maegele; U Nienaber; T Paffrath; R Lefering
Journal:  Unfallchirurg       Date:  2018-10       Impact factor: 1.000

Review 6.  What Is the Biological and Clinical Relevance of Fibrin?

Authors:  Rustem I Litvinov; John W Weisel
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

7.  A Fibrin Cross-linking Polymer Enhances Clot Formation Similar to Factor Concentrates and Tranexamic Acid in an in vitro Model of Coagulopathy.

Authors:  Leslie W Chan; Nathan J White; Suzie H Pun
Journal:  ACS Biomater Sci Eng       Date:  2016-01-28

8.  Rotational thromboelastometry thresholds for patients at risk for massive transfusion.

Authors:  Gregory R Stettler; Ernest E Moore; Geoffrey R Nunns; Jim Chandler; Erik Peltz; Christopher C Silliman; Anirban Banerjee; Angela Sauaia
Journal:  J Surg Res       Date:  2018-04-11       Impact factor: 2.192

9.  Efficacy of a high FFP:PRBC transfusion ratio on the survival of severely injured patients: a retrospective study in a single tertiary emergency center in Japan.

Authors:  Daisuke Kudo; Junichi Sasaki; Satoshi Akaishi; Satoshi Yamanouchi; Tomoaki Koakutsu; Tomoyuki Endo; Takeaki Sato; Ryosuke Nomura; Hironao Yuzawa; Michio Kobayashi; Yotaro Shinozawa; Shigeki Kushimoto
Journal:  Surg Today       Date:  2013-02-19       Impact factor: 2.549

10.  The effect of fibrinogen concentrate and factor XIII on thromboelastometry in 33% diluted blood with albumin, gelatine, hydroxyethyl starch or saline in vitro.

Authors:  Christoph Johannes Schlimp; Janne Cadamuro; Cristina Solomon; Heinz Redl; Herbert Schöchl
Journal:  Blood Transfus       Date:  2012-12-13       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.